R O Cannon - Concepedia

Author

R O Cannon

National Heart Lung and Blood Institute

Also Known As

R O Cannon, R. O. Cannon, R.O. Cannon, Richard O. Cannon

Publications

5.7K

Citations

H-Index

Concepts

All Affiliations

National Heart Lung and Blood Institute National Institutes of Health Leoni (Germany)A.S. Watson (Netherlands)National Institutes of Health Clinical Center

About

R O Cannon is an author at National Heart Lung and Blood Institute specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	18	2.9K
2	Public Health	11	11	2.1K
3	Health Sciences	3	3	623
4	Social Sciences	1	1	44
5	Cardiothoracic Surgery	1	1	44

R O Cannon

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
Acute vascular effects of estrogen in postmenopausal women. David Gilligan, D M Badar, Julio A. Panza, Circulation	1994	555
Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. David Gilligan, Arshed A. Quyyumi, R O Cannon Circulation	1994	542
Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women Michael N. Sack, D J Rader, R O Cannon The Lancet GynecologyPatch AdministrationOxidative StressMetabolic SyndromeAntioxidant Effect	1994	524
Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. R O Cannon, Douglas R. Rosing, Barry J. Maron, Circulation Myocardial IschemiaHeart FailureInadequate Vasodilator ReservePeak PacingPacing Study	1985	474
Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. Arshed A. Quyyumi, Nader Dakak, Syed Husain, Journal of Clinical Investigation HypertensionVascular DiseaseNitric OxideNitric Oxide ActivityCoronary Artery Disease	1995	447
Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy. Lameh Fananapazir, R O Cannon, Dominique Tripodi, Circulation	1992	296
Left ventricular dysfunction in patients with angina pectoris, normal epicardial coronary arteries, and abnormal vasodilator reserve. R O Cannon, Robert O. Bonow, Stephen L. Bacharach, Circulation HypertensionHeart FailureAngina PectorisDiastolic FunctionCoronary Artery Disease	1985	240
Endothelial dysfunction in patients with chest pain and normal coronary arteries. Arshed A. Quyyumi, R O Cannon, Julio A. Panza, Circulation	1992	234
Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Lameh Fananapazir, Cynthia M. Tracy, M.B. Leon, Circulation Heart FailureElectrophysiologic AbnormalitiesConsecutive AnalysisElectrophysiological EvaluationSupraventricular Tachycardia	1989	203
Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. R O Cannon, Vasken Dilsizian, P T O'Gara, Circulation	1991	163

Page 1